
The impact of the potential ban would have serious consequences for the availability of many drugs for European patients.
David R. Schoneker is chairman of the International Pharmaceutical Excipients Council of the Americas. He also is director of global regulatory affairs at Colorcon.

The impact of the potential ban would have serious consequences for the availability of many drugs for European patients.

This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.

Natural gums and mucilage are biocompatible, cheap, readily available, and represent a potential source of excipients. The authors examine the functionality of mucilage extracted from the leaves of Hibiscus rosa-sinensis Linn as an excipient in a sustained-release tablet formulation.

As China emerges as a significant supplier of pharmaceutical ingredients, it must assure other countries of the safety of its excipients.

Published: March 15th 2023 | Updated:

Published: October 4th 2007 | Updated:

Published: January 2nd 2008 | Updated:

Published: October 2nd 2017 | Updated: